| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 05/11/2011 | CN101347514B Health medical pillow |
| 05/11/2011 | CN101342331B Traditional Chinese medicine for treating pulmonitis and upper respiratory tract infection |
| 05/11/2011 | CN101306027B Extracting method of medical mangrove acanthus total flavonoids |
| 05/11/2011 | CN101200684B Health-care fragrant grape wine and method for preparing same |
| 05/11/2011 | CN101199648B Chinese medicine agent for treating chronicity tonsillitis |
| 05/11/2011 | CN101152267B Method of preparing anticold grain based on ultrasound wave auxiliary extraction technology |
| 05/11/2011 | CN101147788B Medicine for treating cold and upper respiratory tract infection and its lung inflammation |
| 05/11/2011 | CN101080405B Quaternary ammonium salts as M3 antagonists |
| 05/10/2011 | US7939670 Nociceptin analogs |
| 05/10/2011 | US7938641 Extrusion die |
| 05/10/2011 | CA2622805C Compressed tablets comprising valsartan |
| 05/10/2011 | CA2531170C Aztreonam l-lysine and methods for the preparation thereof |
| 05/10/2011 | CA2485535C Modified release pharmaceutical formulation |
| 05/10/2011 | CA2483105C Autoimmune conditions and nadph oxidase defects |
| 05/10/2011 | CA2478335C Amino-methyl substituted tetracycline compounds |
| 05/10/2011 | CA2475498C Piperidine derivative and pharmaceutical composition comprising the same as active ingredient |
| 05/10/2011 | CA2463102C Pyrazolidinone compounds as ligands of the prostaglandin ep2 and/or ep4 receptors |
| 05/10/2011 | CA2436935C Serine protease inhibitors |
| 05/10/2011 | CA2419633C Substituted imidazoles as tafia inhibitors |
| 05/10/2011 | CA2418815C Polysaccharides with antithrombotic activity comprising at least a covalent bond with biotin or a biotin derivative |
| 05/05/2011 | WO2011052706A1 Dry powder inhaler of tranilast having high solubility |
| 05/05/2011 | WO2011051673A1 Aminothiazole derivatives useful as klk1 inhibitors |
| 05/05/2011 | WO2011051672A1 Azaindole derivatives |
| 05/05/2011 | WO2011051671A1 Aminopyridine derivatives as kallikrein inhibitors |
| 05/05/2011 | WO2011051375A1 2-aryl-propionamide derivatives useful as bradykinin receptor antagonists and pharmaceutical compositions containing them |
| 05/05/2011 | WO2011050590A1 Polymorph of 3-(substituteddihydroisoindolinone-2-yl)-2,6-dioxopiperidine, and pharmaceutical compositions thereof |
| 05/05/2011 | WO2011031713A8 Method for the treatment of pulmonary disease and method of producing proteins of use therein |
| 05/05/2011 | WO2011005306A3 Production of and uses for decellularized lung tissue |
| 05/05/2011 | WO2009071990A3 No-donating cordicosteroid with improved pharmacokinetic, anti-inflammatory and vasodilatory properties |
| 05/05/2011 | US20110107443 Novel protein transduction domains derived from secretory leukocyte protease inhibitor |
| 05/05/2011 | US20110106241 Compositions and methods for inhibiting sphingosine kinase |
| 05/05/2011 | US20110105607 Lipophilic diesters of chelating agent for inhibition of enzyme activity |
| 05/05/2011 | US20110105601 Compositions for use in treating or preventing metabolic stress-induced lung injury and methods for increasing physical capacity of mammalian livestock |
| 05/05/2011 | US20110105584 Rtp80il sirna compounds and methods of use thereof |
| 05/05/2011 | US20110105573 Benzimidazole acetic acids exhibiting crth2 receptor antagonism and uses thereof |
| 05/05/2011 | US20110105562 Alkynyl derivatives useful as dpp-1 inhibitors |
| 05/05/2011 | US20110105538 Drug response markers |
| 05/05/2011 | US20110105537 5,7-disubstituted thiazolo[4,5-d]pyrimidines for the selective inhibition of chemokine receptors |
| 05/05/2011 | US20110105535 Inhibitors of phosphatidylinositol 3-kinase |
| 05/05/2011 | US20110105509 Indole based receptor crth2 antagonists |
| 05/05/2011 | US20110105505 Thiazolyl piperidine derivatives |
| 05/05/2011 | US20110105499 Pyrazolo-Pyrazinone Compounds and Methods of Use Thereof |
| 05/05/2011 | US20110105498 Pyrazolo-pyridinone and pyrazolo-pyrazinone compounds as P38 modulators and methods of use thereof |
| 05/05/2011 | US20110105479 Inhibitors of Bruton's Tyrosine Kinase |
| 05/05/2011 | US20110105478 Novel 1,4-diaza-bicyclo[3.2.2]nonyl oxadiazolyl derivatives useful as modulator of nicotinic acetylcholine receptors |
| 05/05/2011 | US20110105459 Azetidines and cyclobutanes as histamine h3 receptor antagonists |
| 05/05/2011 | US20110105458 Fatty acid inhibitors |
| 05/05/2011 | US20110105455 Phenoxy-substituted pyrimidines as opioid receptor modulators |
| 05/05/2011 | US20110105449 Dry powder formulations comprising ascorbic acid derivates |
| 05/05/2011 | US20110105447 Novel modulators of calcium release-activated calcium channel |
| 05/05/2011 | US20110105440 HEXAHYDROCYCLOPENTYL[f]INDAZOLE SULFONAMIDES AND DERIVATIVES THEREOF AS SELECTIVE GLUCOCORTICOID RECEPTOR MODULATORS |
| 05/05/2011 | US20110105432 Aminocarboxylic acid derivative and medicinal use thereof |
| 05/05/2011 | US20110105430 Pyrrolo [2,3-c] pyridine derivatives as p38 kinease inhibiting agents |
| 05/05/2011 | US20110105427 Deazapurines and uses thereof |
| 05/05/2011 | US20110105414 Cyclic, cystein-free protein |
| 05/05/2011 | US20110105399 Prevention and treatment of inflammation and organ injury after ischemia/reperfusion using mfg-e8 |
| 05/05/2011 | US20110105396 Tgf-beta3 mutants |
| 05/05/2011 | US20110104308 Treatment For Diseases Relying On Discovery That Thioredoxin Mediates Nitric Oxide |
| 05/05/2011 | US20110104276 Pharmaceutical composition containing as an active ingredient 5-methyl-1-phenyl-2-(1h)-pyridone |
| 05/05/2011 | US20110104273 Gastric retentive pharmaceutical compositions for immediate and extended release of phenylephrine |
| 05/05/2011 | US20110104272 Gastric retentive extended-release dosage forms comprising combinations of acetaminophen and phenylephrine |
| 05/05/2011 | US20110104263 Claudin-4 binding peptides, compositions and methods of use |
| 05/05/2011 | US20110104255 Therapeutic agent for fibroid lung |
| 05/05/2011 | US20110104217 Bioactive Peptides and Method of Using Same |
| 05/05/2011 | US20110104207 Gyrase inhibitors and uses thereof |
| 05/05/2011 | US20110104186 Small molecule immunopotentiators and assays for their detection |
| 05/05/2011 | US20110104185 Antibody fragment-polymer conjugates and uses of same |
| 05/05/2011 | US20110104175 Methods of treatment for pulmonary fibrosis |
| 05/05/2011 | US20110104172 Inhibitors of gm-csf and il-17 for therapy |
| 05/05/2011 | US20110104170 Novel composition and methods for the treatment of immune related diseases |
| 05/05/2011 | US20110104166 Methods and Compositions for Treating Polyps |
| 05/05/2011 | US20110104145 Method for the treatment or prophylaxis of chronic inflammatory diseases |
| 05/05/2011 | US20110104113 Ejection liquid, ejection method, method of making droplets from liquid, cartridge and ejection device |
| 05/05/2011 | DE102009027754A1 Verfahren zur Hemmung der Reifung von dendritischen Zellen A method of inhibiting the maturation of dendritic cells |
| 05/04/2011 | EP2316941A2 Compositions and their uses directed to IL-4R alpha |
| 05/04/2011 | EP2316852A1 Stabilized single domain antibodies |
| 05/04/2011 | EP2316851A1 Antibody inhibitors of GDF-8 and uses thereof |
| 05/04/2011 | EP2316820A1 2-aryl-propionamide derivatives useful as bradykinin receptor antagonists and pharmaceutical compositions containing them |
| 05/04/2011 | EP2316487A1 Recombinant IL-9 antibodies & uses thereof |
| 05/04/2011 | EP2316466A2 Gram positive bacteria preparations for the treatment of diseases comprising an immune dysregulation |
| 05/04/2011 | EP2316455A1 Pharmaceutical compositions for treating cancer |
| 05/04/2011 | EP2316451A1 Use of melatonin in preventing postoperative complications |
| 05/04/2011 | EP2316450A1 Amino-methyl substituted tetracycline compounds |
| 05/04/2011 | EP2315765A2 Solid forms of (1r,2s,3r)-1-(2-(isoxazol-3-yl)-1h-imidazol-4-yl)butane-1,2,3,4-tetraol and methods of their use |
| 05/04/2011 | EP2315756A2 1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase |
| 05/04/2011 | EP2315754A1 Pyrimidyl sulfonaminde derivative and its use for the treatment of chemokine mediated diseases |
| 05/04/2011 | EP2315591A1 Novel pyrrole inhibitors of s-nitrosoglutathione reductase as therapeutic agents |
| 05/04/2011 | EP2315589A1 PHARMACEUTICAL PRODUCT COMPRISING A MUSCARINIC RECEPTOR ANTAGONIST AND A beta2-ADRENOCEPTOR AGONIST |
| 05/04/2011 | EP1761509B1 Substituted cycloalkyl derivatives for the treatment of respiratory diseases |
| 05/04/2011 | EP1706099B1 A medical product comprising tiotropium in a moisture-proof container |
| 05/04/2011 | EP1429742B1 Modified release dosage forms |
| 05/04/2011 | EP1317448B2 Pyrazole compounds useful as protein kinase inhibitors |
| 05/04/2011 | CN1923232B Medicine composition for dispersing pathogenic wind and extinguishing phlegm, absorbing clots and softening hard masses, preparation method and use thereof |
| 05/04/2011 | CN1847229B 2,4,8- trisubstituted-8H- pyridine[2,3-d] pyridine -7-one compound |
| 05/04/2011 | CN102046208A Composition for external application comprising transcription factor decoy as active ingredient |
| 05/04/2011 | CN102046202A Stabilizing lipid compositions for oral pharmaceutical agents |
| 05/04/2011 | CN102046165A Methods of treating fibrotic disorders |
| 05/04/2011 | CN102040643A Ciclesonide nitrate derivative |
| 05/04/2011 | CN102040602A 毒蕈碱性乙酰胆碱受体拮抗剂 Muscarinic acetylcholine receptor antagonist |
| 05/04/2011 | CN102040601A 1-N-(1-azabicyalo(2,2,2) octane ether compound and application thereof |